Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Total Non-Current Liabilities (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $43.8 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 13.56% to $43.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.8 million through Dec 2025, down 13.56% year-over-year, with the annual reading at $43.8 million for FY2025, 13.56% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $43.8 million at Werewolf Therapeutics, down from $47.4 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $74.0 million in Q1 2023, with the low at $7.1 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $43.1 million, with a median of $47.1 million recorded in 2024.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 411.14% in 2022, then fell 29.7% in 2024.
  • Over 5 years, Total Non-Current Liabilities stood at $26.5 million in 2021, then surged by 42.53% to $37.7 million in 2022, then soared by 68.25% to $63.5 million in 2023, then fell by 20.09% to $50.7 million in 2024, then dropped by 13.56% to $43.8 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $43.8 million, $47.4 million, and $48.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.